GlaxoSmithKline | GSK

Stock Price
2,144.00
Daily Change
37.00 1.76%
Monthly
1.04%
Yearly
46.30%
Q2 Forecast
2,004.95

EPS Reference Time Actual Consensus Previous
2026-04-29 FY2026Q1 AM 0.43 0.45
2026-02-04 FY2025Q4 AM 0.26 0.24 0.23
2025-10-29 FY2025Q3 AM 0.55 0.47 0.50
2025-07-30 FY2025Q2 AM 0.47 0.43 0.43
2025-04-30 FY2025Q1 PM 0.45 0.41 0.43



Peers Price Chg Day Year Date
AbbVie 208.84 -6.14 -2.86% 3.57% Apr/02
Alcon AG 60.32 0.24 0.40% -23.06% Apr/02
Almirall 12.32 0.02 0.16% 27.34% Apr/02
Amgen 347.94 -5.34 -1.51% 12.29% Apr/02
argenx SE 647.20 1.40 0.22% 20.57% Apr/02
AstraZeneca 15,316.00 294.00 1.96% 34.45% Apr/02
Bayer 39.70 -0.43 -1.06% 86.67% Apr/02
Biogen 177.34 -6.44 -3.50% 35.67% Apr/02
Bristol-Myers Squibb 59.60 -2.13 -3.45% 3.08% Apr/02
Fresenius Medical Care 38.67 0.08 0.21% -17.09% Apr/02

Indexes Price Day Year Date
GB100 10436 71.50 0.69% 23.15% Apr/02
EU600 597 0.01 0.002% 20.21% Apr/03

GlaxoSmithKline traded at 2,144.00 this Thursday April 2nd, increasing 37.00 or 1.76 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline gained 1.04 percent. Over the last 12 months, its price rose by 46.30 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 2,004.95 by the end of this quarter and at 1,878.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.



News Stream
GlaxoSmithKline Stock Price Hits 4-week High
GlaxoSmithKline shares increased to 2126.00 GBp, the highest since March 2026. Over the past 4 weeks, GlaxoSmithKline gained 0.12%, and in the last 12 months, it increased 44.97%.
2026-04-02
GlaxoSmithKline Stock Price Hits 6-week Low
GlaxoSmithKline shares decreased to 1945.00 GBp, the lowest since February 2026. Over the past 4 weeks, GlaxoSmithKline lost 12.09%, and in the last 12 months, it increased 28.76%.
2026-03-19
GlaxoSmithKline Stock Price Hits 4-week Low
GlaxoSmithKline shares decreased to 2107.00 GBp, the lowest since February 2026. Over the past 4 weeks, GlaxoSmithKline lost 4%, and in the last 12 months, it increased 40.62%.
2026-03-05